Cardiovascular disease (CVD) is the common leading cause of death among people with spinal cord injury (SCI) and occurs at an early age in people with SCI as compared to able-bodied people. The findings are consistent in demonstrating a high prevalence of CVD among people with SCI. Lack of physical activity and/or prolonged sitting which is observed in people with SCI due to impaired/loss of motor function is associated with increased risk factors of CVD. By doing this study, researchers hope to learn the effects of walking training on cardiovascular health among people with chronic SCI.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
15
Participants will receive three sessions a week of BWSTT with assistive training device for 8 weeks; a total of 24 sessions. The duration of each training session will an hour. During walk-training, the participant will wear a harness which is attached to an overhead motorized lift to provide body-weight support and to prevent the risk of falling.
University of Kansas Medical Center
Kansas City, Kansas, United States
The recruitment feasibility of an 8-week (3 sessions per week, 30 min per session) walk-training program in patients with chronic SCI.
Recruitment rate will be assessed by recording the number of participants who are screened for eligibility, those who are excluded because of eligibility criteria, and those who decline to participate in the study.
Time frame: From baseline to week 8
The perception feasibility of an 8-week (3 sessions per week, 30 min per session) walk-training program in patients with chronic SCI.
Information on perception will be acquired through a questionnaire that will be administered to participants at the end of walk-training program.
Time frame: From baseline to week 8
The compliance feasibility of an 8-week (3 sessions per week, 30 min per session) walk-training program in patients with chronic SCI.
Data on compliance rate will be documented during a period of training. The total number of completed sessions and incomplete sessions along with reasons for absence will be recorded throughout the study.
Time frame: From baseline to week 8
The retention feasibility of an 8-week (3 sessions per week, 30 min per session) walk-training program in patients with chronic SCI.
Data on retention will be obtained by recording the number of participants who drop out during the study along with their reasons.
Time frame: From baseline to week 8
The walking performance (walking time) feasibility of an 8-week walk-training program in patients with chronic SCI.
The time of walking (minutes) that a participant will be able to walk on a treadmill during each training session will be recorded.
Time frame: From baseline to week 8
The walking performance (treadmill walking speed) feasibility of an 8-week walk-training program in patients with chronic SCI.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The amount of treadmill speed (miles/hour) that a participant will be able to walk will be recorded during each training session.
Time frame: From baseline to week 8
The walking performance (number of stepping) feasibility of an 8-week walk-training program in patients with chronic SCI.
The number of stepping during each training session will be recorded using a step tracker.
Time frame: From baseline to week 8
Correlations between changes in four factors (muscle activity, cardiac autonomic function, spasticity, and lung capacity) and changes in heart rate after the walk-training program.
The resting heart rate will be measured during sitting position after 5 minutes rest. Exercise heart rate will be measured during a graded treadmill walking test with the same testing conditions pre- and post-training. The signal activity of four muscles in the lower limbs (biceps femoris, rectus femoris, gastrocnemius medialis, and tibialis anterior) will be measured using electromyography (EMG) system. The EMG recording will be obtained during walking on a treadmill. The average root-mean-square EMG for each muscle during gait cycle will be calculated. Cardiac autonomic function will be determined through power spectral of heart rate variability (HRV) using electrocardiography system. HRV frequency domain, including total power, low frequency (LF) and high frequency (HF) powers, and ratio of LF/HF, will be calculated and analyzed. Muscle spasticity for the lower extremities will be assessed through Modified Tardieu Scale. lung capacity will be measured through a spirometer.
Time frame: Change from baseline to week 8
Changes in lipid profile after 8-week walk-training program.
For lipid profile, we will assess serum concentrations of total cholesterol, low density lipoprotein and high density lipoprotein using an enzymatic colorimetric assay.
Time frame: Change from baseline to week 8
Changes in the level of glycated hemoglobin (HbA1c) after 8-week walk-training program.
The level of HbA1c will be assessed using a device A1CNow+ System.
Time frame: Change from baseline to week 8
Changes in the level of pro-inflammatory markers after 8-week walk-training program.
For inflammatory markers, serum concentrations of C-reactive protein and interleukin-6 will be determined using an enzyme-linked immunosorbent assay.
Time frame: Change from baseline to week 8